Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | USP22 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | SLC39A7 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | ACP1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | SPANXN3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | TDG | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | POLDIP3 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | CSK | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | TXLNB | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | NOTCH4 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | TG | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |